Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China

References

• Klarenbeek NB, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF. Recent advances in the management of rheumatoid arthritis. BMJ. 2010;341(dec21 1):c6942. doi:10.1136/bmj.c6942
   Web of Science ®Google Scholar
• Deighton C, O’Mahony R, Tosh J, Turner C, Rudolf M. Guideline Development G. Management of rheumatoid arthritis: summary of NICE guidance. BMJ. 2009;338(mar16 1):b702. doi:10.1136/bmj.b702
   Web of Science ®Google Scholar
• Rindfleisch JA, Muller D. Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2005;72(6):1037–1047.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Landewe R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis. 2017;76(6):960–977. doi:10.1136/annrheumdis-2016-210715
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Prim. 2018;4(1):18001. doi:10.1038/nrdp.2018.1
   PubMed Web of Science ®Google Scholar
• Baker JF, Sauer B, Teng -C-C, et al. Initiation of disease-modifying therapies in rheumatoid arthritis is associated with changes in blood pressure. J Clin Rheumatol. 2018;24(4):203–209. doi:10.1097/RHU.0000000000000736
   Web of Science ®Google Scholar
• Wilsdon TD, Hill CL. Managing the drug treatment of rheumatoid arthritis. Aust Prescr. 2017;40(2):51–58. doi:10.18773/austprescr.2017.012
   PubMed Web of Science ®Google Scholar
• Bowling A, Ebrahim S. Measuring patients’ preferences for treatment and perceptions of risk. Qual Health Care. 2001;10(Suppl 1):i2–8. doi:10.1136/qhc.0100002
   PubMedGoogle Scholar
• Barton JL. Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy. Patient Prefer Adherence. 2009;3:335–344. doi:10.2147/PPA
   PubMed Web of Science ®Google Scholar
• Louder AM, Singh A, Saverno K, et al. Patient preferences regarding rheumatoid arthritis therapies: a conjoint analysis. Am Health Drug Benefits. 2016;9:84–93.
   PubMed Web of Science ®Google Scholar
• Marengo MF, Suarez-Almazor ME. Improving treatment adherence in patients with rheumatoid arthritis: what are the options? Int J Clin Rheumatol. 2015;10(5):345–356. doi:10.2217/ijr.15.39
   PubMedGoogle Scholar
• Gadallah MA, Boulos DN, Gebrel A, Dewedar S, Morisky DE. Assessment of rheumatoid arthritis patients’ adherence to treatment. Am J Med Sci. 2015;349(2):151–156. doi:10.1097/MAJ.0000000000000376
   Web of Science ®Google Scholar
• Atkinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health. 2005;8(Suppl 1):S9–S24. doi:10.1111/j.1524-4733.2005.00066.x
   PubMed Web of Science ®Google Scholar
• Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2(1):12. doi:10.1186/1477-7525-2-12
   PubMedGoogle Scholar
• Khanna PP, Shiozawa A, Walker V, et al. Health-related quality of life and treatment satisfaction in patients with gout: results from a cross-sectional study in a managed care setting. Patient Prefer Adherence. 2015;9:971–981. doi:10.2147/PPA.S83700
   PubMed Web of Science ®Google Scholar
• Jobanputra P, Maggs F, Deeming A, et al. A randomised efficacy and discontinuation study of etanercept versus adalimumab (RED SEA) for rheumatoid arthritis: a pragmatic, unblinded, non-inferiority study of first TNF inhibitor use: outcomes over 2 years. BMJ Open. 2012;2.
   Web of Science ®Google Scholar
• Lin Q, Lin Z, Gu J, et al. Abnormal high-expression of CD154 on T lymphocytes of ankylosing spondylitis patients is down-regulated by etanercept treatment. Rheumatol Int. 2010;30(3):317–323. doi:10.1007/s00296-009-0958-8
   Web of Science ®Google Scholar
• Bharmal M, Payne K, Atkinson MJ, Desrosiers MP, Morisky DE, Gemmen E. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes. 2009;7:36. doi:10.1186/1477-7525-7-36
   PubMed Web of Science ®Google Scholar
• Yu C, Li M, Duan X, et al. Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis. Clin Exp Rheumatol. 2018;36:836–840.
   PubMed Web of Science ®Google Scholar
• Jin S, Li M, Fang Y, et al. Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis. Arthritis Res Ther. 2017;19:251.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/art.27584
   PubMed Web of Science ®Google Scholar
• Yin R, Cao H, Fu T, et al. The rate of adherence to urate-lowering therapy and associated factors in Chinese gout patients: a cross-sectional study. Rheumatol Int. 2017;37:1187–1194. doi:10.1007/s00296-017-3746-x
   PubMed Web of Science ®Google Scholar
• Delestras S, Roustit M, Bedouch P, et al. Comparison between two generic questionnaires to assess satisfaction with medication in chronic diseases. PLoS One. 2013;8:e56247. doi:10.1371/journal.pone.0056247
   PubMed Web of Science ®Google Scholar
• Vermersch P, Hobart J, Dive-Pouletty C, Bozzi S, Hass S, Coyle PK. Measuring treatment satisfaction in MS: is the Treatment Satisfaction Questionnaire for Medication fit for purpose? Multiple Sclerosis. 2017;23(4):604–613. doi:10.1177/1352458516657441
   PubMed Web of Science ®Google Scholar
• Regnault A, Balp -M-M, Kulich K, Viala-Danten M. Validation of the Treatment Satisfaction Questionnaire for Medication in patients with cystic fibrosis. J Cystic Fibrosis. 2012;11(6):494–501. doi:10.1016/j.jcf.2012.04.007
   Web of Science ®Google Scholar
• Van den Bosch F, Ostor AJK, Wassenberg S, et al. Impact of participation in the adalimumab (Humira) patient support program on rheumatoid arthritis treatment course: results from the PASSION study. Rheumatol Ther. 2017;4(1):85–96. doi:10.1007/s40744-017-0061-7
   PubMed Web of Science ®Google Scholar
• Daniel SR, McDermott JD Jr, Le C, Pierce CA, Ziskind MA, Ellis LA. A real-world, multi-site, observational study of infusion time and treatment satisfaction with rheumatoid arthritis patients treated with intravenous golimumab or infliximab. J Med Econ. 2018;1–8.
   Web of Science ®Google Scholar
• Marshall NJ. Patients’ perceptions of treatment with anti-TNF therapy for rheumatoid arthritis: a qualitative study. Rheumatology. 2004;43(8):1034–1038. doi:10.1093/rheumatology/keh237
   Web of Science ®Google Scholar
• van Tuyl LH, Plass AM, Lems WF, et al. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis. Rheumatology. 2008;47(10):1571–1576. doi:10.1093/rheumatology/ken323
   PubMed Web of Science ®Google Scholar
• Carbonell J, Badia X, grupo E. Expectations, preferences and satisfaction of patients with rheumatoid arthritis receiving infliximab treatment. Med Clin (Barc). 2008;131:493–499.
   PubMed Web of Science ®Google Scholar
• Kjeken I, Dagfinrud H, Mowinckel P, Uhlig T, Kvien TK, Finset A. Rheumatology care: involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum. 2006;55:394–401. doi:10.1002/art.21985
   PubMed Web of Science ®Google Scholar
• Rao JK, Weinberger M, Anderson LA, Kroenke K. Predicting reports of unmet expectations among rheumatology patients. Arthritis Rheum. 2004;51(2):215–221. doi:10.1002/art.20246
   Web of Science ®Google Scholar
• Wolfe F, Michaud K. Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients’ treatment choices. Arthritis Rheum. 2007;56:2135–2142. doi:10.1002/art.22719
   PubMed Web of Science ®Google Scholar
• Henao S, Rodriguez F, Santos-Moreno P, et al. patient satisfaction in a rheumatoid arthritis specialized center. Ann Rheum Dis. 2016;76:AB1207–HPR.
   Google Scholar
• Calvo-Alen J, Vela P, Bustabad S, Maceiras F, Carmona L, Cea-Calvo L. Satisfaction, fulfillment of expectations and adherence to subcutaneous biological drugs in patients with rheumatoid arthritis: ARCO study. Rheumatol Clin. 2018. doi:10.1016/j.reuma.2018.04.002
   Google Scholar
• Ward MM, Guthrie LC, Alba MI. Standards of comparison and discordance in rheumatoid arthritis global assessments between patients and clinicians. Arthritis Care Res (Hoboken). 2017;69:1260–1265. doi:10.1002/acr.23103
   Web of Science ®Google Scholar
• De Mits S, Lenaerts J, Vander Cruyssen B, et al. A nationwide survey on patient’s versus physician s evaluation of biological therapy in rheumatoid arthritis in relation to disease activity and route of administration: the be-raise study. PLoS One. 2016;11(11):e0166607. doi:10.1371/journal.pone.0166607
   Web of Science ®Google Scholar
• Rein P, Mueller RB. Treatment with biologicals in rheumatoid arthritis: an overview. Rheumatol Ther. 2017;4(2):247–261. doi:10.1007/s40744-017-0073-3
   PubMed Web of Science ®Google Scholar
• Choy E, Aletaha D, Behrens F, et al. Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis. Rheumatology. 2017;56(5):689–697. doi:10.1093/rheumatology/kew271
   PubMed Web of Science ®Google Scholar
• Bechman K, Sin FE, Ibrahim F, et al. Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial. RMD Open. 2018;4(1):e000676. doi:10.1136/rmdopen-2018-000676
   Web of Science ®Google Scholar
• Matcham F, Galloway J, Hotopf M, et al. The impact of targeted rheumatoid arthritis pharmacologic treatment on mental health: a systematic review and network meta-analysis. Arthritis Rheumatol. 2018;70(9):1377–1391. doi:10.1002/art.40565
   Web of Science ®Google Scholar
• Asadi-Lari M, Tamburini M, Gray D. Patients’ needs, satisfaction, and health related quality of life: towards a comprehensive model. Health Qual Life Outcomes. 2004;2(1):32. doi:10.1186/1477-7525-2-32
   PubMedGoogle Scholar
• Basinska MA, Drozdowska M. Emotional intelligence as an indicator of satisfaction with life of patients with psoriasis. Postepy Dermatol Alergol. 2013;30:365–372. doi:10.5114/pdia.2013.39435
   Web of Science ®Google Scholar
• Barton JL, Imboden J, Graf J, Glidden D, Yelin EH, Schillinger D. Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2010;62(6):857–864. doi:10.1002/acr.20132
   PubMed Web of Science ®Google Scholar
• Walker UA, Mueller RB, Jaeger VK, et al. Disease activity dynamics in rheumatoid arthritis: patients’ self-assessment of disease activity via WebApp. Rheumatology (Oxford). 2017;56(10):1707–1712. doi:10.1093/rheumatology/kex229
   Web of Science ®Google Scholar
• Aoki A, Suda A, Takeno M, Ishigatsubo Y, Maeda I. Determinants of factors influencing patient satisfaction in rheumatoid arthritis. Clin Rheumatol Rel Res. 2010;22:42–50.
   Google Scholar
• Smolen JS, Breedveld FC, Burmester GR, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3–15. doi:10.1136/annrheumdis-2015-207524
   PubMed Web of Science ®Google Scholar
• Lofland JH, Johnson PT, Ingham MP, Rosemas SC, White JC, Ellis L. Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs. Patient Prefer Adherence. 2017;11:947–958. doi:10.2147/PPA.S133222
   PubMed Web of Science ®Google Scholar
• Feinberg J. The effect of patient-practitioner interaction on compliance: a review of the literature and application in rheumatoid arthritis. Patient Educ Couns. 1988;11(3):171–187. doi:10.1016/0738-3991(88)90018-3
   Web of Science ®Google Scholar
• Cea-Calvo L, Raya E, Marras C, et al. The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern. Rheumatol Int. 2018.
   Web of Science ®Google Scholar
• Jing S, Yin A, Shi L, Liu J. Whether new cooperative medical schemes reduce the economic burden of chronic disease in rural China. PLoS One. 2013;8:e53062. doi:10.1371/journal.pone.0053062
   PubMed Web of Science ®Google Scholar
• Wang P, Luo D, Lu F, et al. A novel mobile app and population management system to manage rheumatoid arthritis flares: protocol for a randomized controlled trial. JMIR Res Protoc. 2018;7(4):e84. doi:10.2196/resprot.8771
   Web of Science ®Google Scholar